(19)
(11) EP 0 954 324 A1

(12)

(43) Date of publication:
10.11.1999 Bulletin 1999/45

(21) Application number: 97917819.0

(22) Date of filing: 02.04.1997
(51) International Patent Classification (IPC): 
A61K 31/ 00( . )
A61K 39/ 00( . )
A61P 3/ 00( . )
A61P 37/ 00( . )
C07K 14/ 47( . )
C12N 15/ 85( . )
A61K 33/ 06( . )
A61K 39/ 39( . )
A61P 3/ 10( . )
A61P 37/ 02( . )
C07K 14/ 74( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1997/005461
(87) International publication number:
WO 1997/036601 (09.10.1997 Gazette 1997/43)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 03.04.1996 US 19960014790P

(71) Applicant: ANERGEN, INC.
Redwood City, CA 94063 (US)

(72) Inventors:
  • REICH, Eva-Pia
    Los Altos, CA 94204 (US)
  • DESHPANDE, Shrikant
    Fremont, CA 94555 (US)

(74) Representative: Brasnett, Adrian Hugh, et al 
Mewburn Ellis York House 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) CYCLIC PEPTIDE VACCINES FOR TREATMENT AND PREVENTION OF DIABETES